These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17900967)

  • 1. The sensitivity and specificity of the 9-item Wearing-off Questionnaire.
    Stacy MA; Murphy JM; Greeley DR; Stewart RM; Murck H; Meng X;
    Parkinsonism Relat Disord; 2008; 14(3):205-12. PubMed ID: 17900967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Q10 questionnaire for detection of wearing-off phenomena in Parkinson's disease.
    Martinez-Martin P; Hernandez B;
    Parkinsonism Relat Disord; 2012 May; 18(4):382-5. PubMed ID: 22243835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the "QUICK" questionnaire--a tool for diagnosis of "wearing-off" in patients with Parkinson's disease.
    Martinez-Martin P; Tolosa E; Hernandez B; Badia X;
    Mov Disord; 2008 Apr; 23(6):830-6. PubMed ID: 18307246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.
    Stacy M; Hauser R; Oertel W; Schapira A; Sethi K; Stocchi F; Tolosa E
    Clin Neuropharmacol; 2006; 29(6):312-21. PubMed ID: 17095894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early DEtection of wEaring off in Parkinson disease: the DEEP study.
    Stocchi F; Antonini A; Barone P; Tinazzi M; Zappia M; Onofrj M; Ruggieri S; Morgante L; Bonuccelli U; Lopiano L; Pramstaller P; Albanese A; Attar M; Posocco V; Colombo D; Abbruzzese G;
    Parkinsonism Relat Disord; 2014 Feb; 20(2):204-11. PubMed ID: 24275586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.
    Stacy MA; Murck H; Kroenke K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):57-61. PubMed ID: 19793544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study.
    Colombo D; Abbruzzese G; Antonini A; Barone P; Bellia G; Franconi F; Simoni L; Attar M; Zagni E; Haggiag S; Stocchi F
    ScientificWorldJournal; 2015; 2015():787451. PubMed ID: 25685848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease.
    Abbruzzese G; Antonini A; Barone P; Stocchi F; Tamburini T; Bernardi L; Amboni M; Vacca L; Posocco V; Colombo D
    Neurol Sci; 2012 Dec; 33(6):1319-27. PubMed ID: 22307444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Japanese version of the 9-item Wearing-off Questionnaire.
    Fukae J; Higuchi MA; Yanamoto S; Fukuhara K; Tsugawa J; Ouma S; Hatano T; Yoritaka A; Okuma Y; Kashihara K; Hattori N; Tsuboi Y
    Clin Neurol Neurosurg; 2015 Jul; 134():110-5. PubMed ID: 25985062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample.
    Santos JG; Chien HF; Barbosa ER
    Arq Neuropsiquiatr; 2014 Nov; 72(11):867-73. PubMed ID: 25410454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease.
    Altavista MC; Cassetta E; Brusa L; Viselli F; Denaro A; Ventriglia M; Pasqualetti P; Peppe A
    Parkinsonism Relat Disord; 2015 Feb; 21(2):95-100. PubMed ID: 25443558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.
    Santens P; de Noordhout AM;
    Acta Neurol Belg; 2006 Sep; 106(3):137-41. PubMed ID: 17091617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Patient Card questionnaire to identify wearing-off in Parkinson disease.
    Martínez-Martín P; Tolosa E; Hernández B; Badia X
    Clin Neuropharmacol; 2007; 30(5):266-75. PubMed ID: 17909304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Translation and linguistic validation of the Japanese version of the wearing-off questionnaires(WOQ-19 and WOQ-9)].
    Kondo T; Takahashi K
    Brain Nerve; 2011 Nov; 63(11):1285-92. PubMed ID: 22068482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wearing-off Identification in Parkinson's Disease: The shapd-woq Study.
    Wan Y; Yuan C; Hou X; Chen W; Wang C; Gao S; Wang Y; Jin L; Liu Z
    Front Neurol; 2020; 11():116. PubMed ID: 32231634
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease.
    Stacy M; Hauser R
    J Neural Transm (Vienna); 2007 Feb; 114(2):211-7. PubMed ID: 16897594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.